Cystic Fibrosis (CF) is the most common autosomal recessive genetic disease with a disease frequency of approximately one in 2,500 newborns, and an estimated carrier frequency of approximately one in 25 individuals in the Caucasian and Ashkenazi Jewish populations. This disease is caused by mutations in two copies of the Cystic Fibrosis Transmembrane Regulator gene (CFTR). Reasons for Referral:
Testing Methodology:Direct Mutation Analysis: This extended CF mutation panel includes: the 23 mutations currently recommended by the ACMG:
Sensitivity:Mutation Analysis: ~ 90% detection in the Caucasian/Non-Ashkenazic population ~ 97% detection in the Ashkenazic Jewish population ~ 69% detection in the African American population ~ 57% detection in the Hispanic American population. (Detection rates according to: Richards et al., 2002. Genetics in Medicine 4: 379-391). Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 10
cc; Child: 5 cc; Infant: 2-3 cc Buccal Sample Collection Instructions Blood and Buccal Collection and Shipping kits are provided free of charge to appropriate referral sources upon request (Call 1-800-411-4363). Requisition form must accompany specimen. Prior to genetic testing, we recommend genetic counseling and informed consent. Contact the laboratory directly to discuss prenatal testing. Turnaround Time:3 weeks CPT Codes and Prices:Mutation Analysis: 83788, 83914x2, 83912, 83900, 83901, 83898, 83891 Shipping InformationForms: >> DNA
Requisition Test Codes:Mutation Analysis: 6014 |